Assessment scales

Number and gender of subjects

Race of subject

Age of subjects, years old

Reliability (Internal consistency), α

Indexes correlated with the scale

References associated with the scale

TDS [15]

Sample1: 58 males  

Japanese

27.6 (±11.1)^a

.81

Years of smoking, CPD

Studies on varenicline treatment [19,20]
Studies developing new tools for assessing nicotine dependence [21,22]

Sample2: 115 males
 
         33 females

43.1 (±15.6)^a

33.0 (±12.4)^a

.76

.77

Years of smoking, CPD, CO levels
None

Sample3: 194 males

NM

.77

Age,
Years of smoking
CPD

WISDM-68 [22]

303 males,
454 females,
18 not identified

638 White
83 African-American
54 others

≥18

Total WISDM-68:
.98- .99
Subscales: .84- .96

Total WISDM-68:
TDS, CO, CPD,
Some subscales:
End of treatment relapse

Replication study [26,27]
Studies on PDM and SDM [28-30]
Brief WISDM [31]

CDS-12,
CDS-5  [33]

Preliminary survey: mail 384, internet 145
(Gender: NM)

NM

18-70

CDS-12: .90
CDS-5: .84

Cotinine,
CPD,
Urge to smoke, Switching from daily to      occasional smoking

Replication studies on predictivity [34,35]

Main survey: 3009
   47% males

32 (range 12-74)

NDSS [24]

Study 1: 317
   57% females

NM

44.2 (±10.3)^a

30-item version, NDSS-T: .84
Factors: .55- .76

30-item version:
CPD,
Difficulty abstaining,
Past severity of withdrawal

Studies comparing some scales [26,38]

Study 2 : 802
   57% females

66% White
31% Black
  3% others

39.2 (±10.6)^a

Study 3: 91
   59% males

81% White

34.5 (±9.0) ^a
(range 20-55)